Loading...
Loading...
Tekmira Pharmaceuticals
TKMR shares climbed 22.52% to $25.90 following the confirmation of first US-diagnosed Ebola case.
Angie's List
ANGI shares gained 21.66% to $7.75 on reports that the company has hired investment bankers to explore strategic options, which would include a sale of the company, according to the Financial Times. Analysts at Northland Securities upgraded Angie's List from Underperform to Market Perform.
Lakeland Industries
LAKE shares gained 12.95% to $7.85. Lakeland makes Hazmat suits for Ebola.
NewLink Genetics
NLNK surged 10.64% to $23.70 on report of US Ebola case in Dallas.
Frontline
FRO gained 10.32% to $1.39. Frontline Management (Bermuda) and Tankers International announced the formation of a new company, VLCC Chartering.
Portola Pharmaceuticals
PTLA shares jumped 9.97% to $27.80 after the company reported that Phase 3 ANNEXA-A study of Andexanet Alfa and Eliquis (Apixaban) met primary and secondary endpoints with high statistical significance.
China Green Agriculture
shares rose 9.09% to $2.16 after the company declared its first cash dividend of $0.10 per share
RCS Capital
RCAP gained 8.44% to $24.42 after the company announced its plans to acquire Cole Capital for $700 million.
Ardelyx
Loading...
Loading...
jumped 7.32% to $15.25 after the company reported positive results from its Phase 2b clinical trial evaluating tenapanor in IBS-C patients.
Mechel OAO
MTL rose 7.08% to $1.21. Russia's VTB Bank said it was not afraid to invest in Mechel.
BioCryst Pharmaceuticals
BCRX shares climbed 5.32% to $10.30. Texas Health officials confirmed the first US-diagnosed Ebola case.
Sarepta Therapeutics
SRPT shares rose 4.74% to $22.10 following the announcement of US-diagnosed Ebola case. Sarepta will present at Leerink Rare Disease Roundtable at 8:00 am ET.
Compugen
CGEN shares rose 2.33% to $8.77 after the company disclosed new results for novel target candidate for cancer immunotherapy.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in